William Wikoff
Nurse Practitioner · Commerce, GANPI 1346832169
Payments from drug & device makers
Across 234 payments — averaging $17.66 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Medtronic$1K
- Salix Pharmaceuticals, A Division Of Bausch Health US, LLC$1K
- Collegium Pharmaceutical, Inc.$633
- Forte Bio-pharma LLC$200
- Scilex Pharmaceuticals Inc.$198
- Nalu Medical, Inc.$167
- plus $571 from 9 others
What the payments were for
- Food & beverage$4,132100%
Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Medtronic | 22 | $1,312 |
| Salix Pharmaceuticals, A Division Of Bausch Health US, LLC | 106 | $1,051 |
| Collegium Pharmaceutical, Inc. | 72 | $633 |
| Forte Bio-pharma LLC | 4 | $200 |
| Scilex Pharmaceuticals Inc. | 9 | $198 |
| Nalu Medical, Inc. | 3 | $167 |
| Foundation Fusion Solutions, LLC | 2 | $154 |
| USWM, LLC | 7 | $147 |
| Curonix LLC | 2 | $143 |
| Biodelivery Sciences International, Inc. | 2 | $30 |
| Vertex | 1 | $22 |
| Amgen | 1 | $21 |
| Arbor Pharmaceuticals, Inc. | 1 | $20 |
| Painteq LLC | 1 | $18 |
| Hikma Pharmaceuticals USA | 1 | $16 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
- INTELLIS ADAPTIVESTIM$624
- Prolate$395
- Nalu Neurostimulation System$143
- TANLOR$132
- Nalocet$132
How this compares
$4,132 in reported general payments places this provider in the 90th percentile of 3,328 nurse practitioner providers in Georgia.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| RelistorMethylnaltrexone Bromide | 77 | $196,060 |
| ZtlidoLidocaine | 59 | $49,708 |
| MovantikNaloxegol Oxalate | 26 | $10,179 |
| Gabapentin | 579 | $6,283 |
| Lidocaine | 49 | $6,042 |
| Diclofenac Sodium | 121 | $2,674 |
| Tizanidine Hcl | 340 | $2,295 |
| Cyclobenzaprine Hcl | 345 | $2,118 |
| Methocarbamol | 91 | $1,163 |
| Baclofen | 115 | $1,077 |
| Duloxetine Hcl | 19 | $465 |
| Celecoxib | 30 | $368 |
| Ondansetron Hcl | 45 | $336 |
| Methylprednisolone | 46 | $315 |
| Ondansetron OdtOndansetron | 15 | $139 |
Paid to pharmacies, not to this prescriber.
Companies that both paid and supply prescribed drugs
These companies both reported payments to this provider and make drugs the provider prescribed under Medicare Part D in 2024. For most specialties this overlap is expected — a cardiologist who is paid by a cardiology drugmaker also treats heart disease. It is shown so the reader can see it, not because it implies anything on its own.
| Company | Paid to this provider | Part D cost of their drugs |
|---|---|---|
| Salix Pharmaceuticals, A Division Of Bausch Health US, LLCRelistor | $1,051 | $196,06077 claims |
| Scilex Pharmaceuticals Inc.Ztlido | $198 | $49,70859 claims |
Reading this fairly. The Part D column is what drug plans and patients paid pharmacies — this provider received none of it, and it reflects how many patients they treat and what those drugs cost. Against peers, this provider's reported payments sit in the 90th percentile of 3,328 nurse practitioner providers in Georgia.
Other nurse practitioner in Commerce
- Crystal LogsdonSavannah$566K
- Victor CzerkasijDalton$505K
- Kennon Mc CollumStockbridge$364K
- Pamela AllenRome$270K
- Tajuana BradleyJohns Creek$256K
- Janice McAlisterAtlanta$241K
- Jessica AdkinsSavannah$226K
- Laura ElledgeAtlanta$177K
- Afsha HussainiKennesaw$122K
- Elizabeth TyeAlbany$78K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Identity: NPPES NPI Registry, July 2026.